Navigation Links
Prestigious International Champalimaud Vision Award to US Scientists
Date:6/13/2010

NEW YORK, June 11 /PRNewswire/ -- The Champalimaud Foundation, one of the world's largest international scientific institutions, announced today that Dr. J. Anthony Movshon, Director of New York University's Center for Neural Studies, and Dr. William T. Newsome, Investigator at The Howard Hughes Medical Institute and Professor of Neurobiology at Stanford University, are the recipients of its 2010 Vision Award.  The prestigious Champalimaud Vision Award, often called the "Nobel Prize for Vision", comes with a $1.3 million prize, the largest monetary prize in the filed of vision and one of the largest scientific and humanitarian prizes in the world.

This year's Vision Award recognizes the work of both Dr. Movshon and Dr. Newsome over the last 30 years.  Working at times together and at other times separately, these outstanding researchers have had a major impact on scientists' understanding of how the brain reconstructs images, so that human beings can perceive, interpret and act in the world.  By building a bridge between psychophysics and human behavior on the one hand and the physiology of individual neurons and what they compute on the other, these two neuroscientists have shed ground-breaking light upon how the brain reconstructs visual images.

Leonor Beleza, President of The Champalimaud Foundation, said, "Visual perception starts with the eyes, but it happens in the brain.  Over a 30 year period, the work of Dr. Movshon and Dr. Newsome has taken this axiom to new scientific levels of understanding.  Because of these two outstanding neuroscientists, we now have a fundamental appreciation for the role of neurons in how we see things move about in the world.  Their ground-breaking work, taken together and individually, has laid the basis for continued research on how the brain and its processes impact vision and perception.  We are very proud to recognize Drs. Movshon and Newsome as the recipients of the 2010 Champalimaud Vision Award."

In his early studies, Dr. Movshon contributed to the understanding of how the brain represents the form and motion of objects, identifying for the first time neural circuits computing motion perception in the brain's middle temporal lobe (MT).  In a joint 1989 study, that is today considered a classic, Drs. Movshon and Newsome demonstrated that neurons in the MT visual area are responsible for perceptual judgments about direction.  By monitoring neuron responses, they could accurately predict decisions about perception, thus linking perception to specific activity within a neural circuit.  Dr. Newsome demonstrated that by altering the activity of neurons, perceptual performance could be either improved or diminished.

These studies proved that the activity of neurons in the brain's MT is necessary in order for human beings to see moving objects in the world.  By unequivocally demonstrating this fact, Drs. Movshon and Newsome paved the way for studies of the mental processes that link perception to action and for a greater understanding of the complex computations that underlie human decision-making and behavior.

The Champalimaud Vision Award

Established by The Champalimaud Foundation in 2006 and referred to as "the Nobel Prize for Vision" by the former President of India, APJ Kalam, the Vision Award has the support of the World Health Organization's (WHO) "VISION 2020:  The Right to Sight Initiative".  In order to provide maximum support for the fight against blindness, the Award concentrates both on practical blindness prevention and on scientific research.  In odd number years, The Vision Award is given for blindness prevention on the ground, particularly in developing countries.  In even numbered years, the Award recognizes outstanding scientific research.  

In 2007, The Vision Award was presented to India's Aravind Eye Care System; in 2008, it was jointly awarded to Drs. King-Wai Yau and Dr. Jeremy Nathans of Johns Hopkins University; and in 2009, Helen Keller International was the recipient.  The Award is given to recipients for outstanding achievement, and the funds are to be used in any way that furthers and amplifies the recipients' scientific efforts.  

The Jury Panel for The Vision Award is comprised of leading international scientists, including two Nobel Laureates, and prominent public figures.  The are: Alfred Sommer (Johns Hopkins University), Mark Bear (MIT), Nobel Laureate Susumu Tonegawa (MIT), Carla Shatz (Stanford University), Joshua Sanes (Harvard University), Paul A. Sieving (NIH), Gullapalli N. Rao (LV Prasad Eye Institute and International Center for Eyecare Education), Nobel Laureate Amartya Sen (Harvard University), Jose Cuhna-Vaz (Coimbra University), Jacques Delors (former President, European Commission), Antonio Guterres (former Prime Minister of Portugal).

The Champalimaud Foundation

The Champalimaud Foundation is a private organization dedicated to the advancement of biomedical science.  With an endowment of euro 500,000,000, the Foundation's work is focused on three core areas: neuroscience research, cancer research, and an outreach program to support the fight against blindness.  Based in Lisbon, Portugal, the Foundation's new research center (Champalimaud Center for the Unknown) is currently under construction and expected to open in Q4 2010.


'/>"/>
SOURCE The Champalimaud Foundation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Patrick Soon-Shiong, M.D. and Michele B. Chan Join Prestigious List of Recipients of KCET Visionary Award at 10th Gala Honoring Region's Philanthropic Leaders
2. Patrick Soon-Shiong, M.D. and Michele B. Chan Join Prestigious List of Recipients of KCET Visionary Award at 10th Gala Honoring Region's Philanthropic Leaders
3. Virtual lab wins prestigious prize awarded by Science
4. Dr. Chang-Hwan Choi honored with prestigious Young Investigator Award
5. DNA Genotek's Oragene•DNA Product Wins Prestigious Medical Design Excellence Award
6. 3 Tufts engineering faculty earn prestigious national awards for promising research
7. Two University of Southern California Innovators Recognized by Technology Reviews Prestigious TR35 Listing of the Worlds Top Young Innovators for 2009
8. Brown engineering professor wins prestigious White House award
9. OpenQ is Awarded Prestigious Life Sciences Industry Award
10. CEL-SCI Presents Data at Prestigious Medical Conference Demonstrating That Its L.E.A.P.S. Technology Stimulates Maturation of Human Blood Cells Into Dendritic Cells Suggesting Potential for Prevention and Treatment of Infectious Disease
11. Lotus Scarless Hair Transplantation (International) Medical Chain Institute Opens New Center on Beijings Prestigious ChangAn Avenue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... N.C. , Feb. 5, 2016  In the ... role for a host of launch activities including the ... of this launch activity is especially high in the ... Best Practices and the Role of Medical ... help companies focused on oncology therapies find better ways ...
(Date:2/5/2016)... FRANCISCO , February 5, 2016 ... a biotechnology company focused on developing products for ... has requested Rare Pediatric Disease Designation (RPDD) from the ... pigmentosa (RP) with MANF. MANF was previously granted orphan ... 2014. --> Amarantus BioScience Holdings, Inc. ...
(Date:2/4/2016)... CA (PRWEB) , ... February 04, 2016 , ... ... enterprise talent development and compliance training, today announced an interactive FDA compliance ... Playbook™. The RAPS (Regulatory Affairs Professional Society) accredited interactive course on Morf ...
(Date:2/4/2016)... , Feb. 4, 2016  Sangamo BioSciences, Inc. (NASDAQ: ... announced today that Edward Lanphier , Sangamo,s president ... the progress of Sangamo,s ZFP Therapeutic ® development ... at 2:40 pm ET on Thursday, February 11, 2016, ... Healthcare Conference. The conference is being held in ...
Breaking Biology Technology:
(Date:2/1/2016)... NEW YORK , Feb. 1, 2016  Today, ... Heart Association (AHA) announced plans to develop a first ... cognitive computing power of IBM Watson. In the first ... disease, AHA, IBM (NYSE: IBM ), and Welltok ... metrics and health assessments with cognitive analytics, delivered on ...
(Date:1/25/2016)... Jan. 25, 2016  Glencoe Software, the world-leading supplier ... publication industries, will provide the data management solution OMERO ... Photo ... Phenotypic analysis measures the characteristics ... allowing comparisons between states such as health and disease, ...
(Date:1/20/2016)... --  MedNet Solutions , an innovative SaaS-based eClinical technology ... is pleased to announce the attainment of record-setting corporate ... of the company,s laser focus on (and growing international ... comprehensive, easy-to-use and highly affordable cloud-based technology platform. ... growth achievements in 2015 include: , Record ...
Breaking Biology News(10 mins):